Impact of gyrA and parC mutations on quinolone resistance, doubling time, and supercoiling degree of Escherichia coli

被引:165
作者
Bagel, S [1 ]
Hüllen, V [1 ]
Wiedemann, B [1 ]
Heisig, P [1 ]
机构
[1] Univ Bonn, D-53115 Bonn, Germany
关键词
D O I
10.1128/AAC.43.4.868
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Isogenic mutants derived from quinolone-susceptible isolate WT by introducing gyrA (S83L, D87G) and parC (S80I, E84K) mutations associated with quinolone resistance were characterized with respect to quinolone resistance, growth rate, and degree of global supercoiling, The latter was determined by use of a pair of reporter plasmids carrying supercoiling-dependent promoters pgyrA and ptopA, respectively, transcriptionally fused to the reporter gene bla coding for TEM-1 beta-lactamase, The quotient (Qsc) of the beta-lactamase specific activity determined for a mutant carrying either plasmid was taken as a measure of the degree of global supercoiling, These Qsc data were comparable to results obtained from the separation of topoisomers of plasmid pBR322 on chloroquine-containing agarose gels and indicate a reduced degree of negative supercoiling in resistant mutants relative to the parent, WT. The S83L mutation in gyrA had the strongest influence on quinolone resistance while leaving other parameters nearly unaffected, The gyrA double mutation (S83L plus D87G) had an effect on quinolone resistance similar to that of a single mutation, Phenotypic expression of the parC mutation (S80I) was dependent on the presence of at least one gyrA mutation, Expression of high-level fluoroquinolone resistance (ciprofloxacin MIG, >4 mu g/ml) required a combination of the gyrA double mutation and one parC mutation (S80I or E84K), Such mutants showed considerable alterations of growth rate, global supercoiling, or both. Introduction of a parC mutation affected neither the doubling time nor the degree of supercoiling, while the presence of the gyrA D87G mutation was associated with a significant reduction in the degree of DNA supercoiling.
引用
收藏
页码:868 / 875
页数:8
相关论文
共 62 条
[1]   NEW ESCHERICHIA-COLI GYRA AND GYRB MUTATIONS WHICH HAVE A GRADED EFFECT ON DNA SUPERCOILING [J].
ALEIXANDRE, V ;
URIOS, A ;
HERRERA, G ;
BLANCO, M .
MOLECULAR & GENERAL GENETICS, 1989, 219 (1-2) :306-312
[2]  
BAGEL S, 1998, COMMUNICATION
[3]   PREVALENCE OF FLUOROQUINOLONE-RESISTANT BACTERIAL ISOLATES IN 4 MEDICAL-CENTERS DURING THE 1ST QUARTER OF 1990 [J].
BARRY, AL ;
FUCHS, PC ;
PFALLER, MA ;
ALLEN, SD ;
GERLACH, EH .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1990, 9 (12) :906-908
[4]   Differential behaviors of Staphylococcus aureus and Escherichia coli type II DNA topoisomerases [J].
Blanche, F ;
Cameron, B ;
Bernard, FX ;
Maton, L ;
Manse, B ;
Ferrero, L ;
Ratet, N ;
Lecoq, C ;
Goniot, A ;
Bisch, D ;
Crouzet, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (12) :2714-2720
[5]   CONSTRUCTION AND CHARACTERIZATION OF NEW CLONING VEHICLES .2. MULTIPURPOSE CLONING SYSTEM [J].
BOLIVAR, F ;
RODRIGUEZ, RL ;
GREENE, PJ ;
BETLACH, MC ;
HEYNEKER, HL ;
BOYER, HW ;
CROSA, JH ;
FALKOW, S .
GENE, 1977, 2 (02) :95-113
[6]   Quinolone resistance locus nfxD of Escherichia coli is a mutant allele of the parE gene encoding a subunit of topoisomerase IV [J].
Breines, DM ;
Ouabdesselam, S ;
Ng, EY ;
Tankovic, J ;
Shah, S ;
Soussy, CJ ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :175-179
[7]   ENDOGENOUS ACTIVE EFFLUX OF NORFLOXACIN IN SUSCEPTIBLE ESCHERICHIA-COLI [J].
COHEN, SP ;
HOOPER, DC ;
WOLFSON, JS ;
SOUZA, KS ;
MCMURRY, LM ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (08) :1187-1191
[8]   CROSS-RESISTANCE TO FLUOROQUINOLONES IN MULTIPLE-ANTIBIOTIC-RESISTANT (MAR) ESCHERICHIA-COLI SELECTED BY TETRACYCLINE OR CHLORAMPHENICOL - DECREASED DRUG ACCUMULATION ASSOCIATED WITH MEMBRANE-CHANGES IN ADDITION TO OMPF REDUCTION [J].
COHEN, SP ;
MCMURRY, LM ;
HOOPER, DC ;
WOLFSON, JS ;
LEVY, SB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) :1318-1325
[9]   CLONING AND CHARACTERIZATION OF A DNA GYRASE-A GENE FROM ESCHERICHIA-COLI THAT CONFERS CLINICAL RESISTANCE TO 4-QUINOLONES [J].
CULLEN, ME ;
WYKE, AW ;
KURODA, R ;
FISHER, LM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (06) :886-894
[10]   ESCHERICHIA-COLI DNA TOPOISOMERASE-I MUTANTS HAVE COMPENSATORY MUTATIONS IN DNA GYRASE GENES [J].
DINARDO, S ;
VOELKEL, KA ;
STERNGLANZ, R ;
REYNOLDS, AE ;
WRIGHT, A .
CELL, 1982, 31 (01) :43-51